Echocardiography in nonbacterial thrombotic endocarditis: from autopsy to clinical entity.

Bacteria-free verrucae, frequently termed "non-bacterial thrombotic endocarditis," have been recognized in autoimmune disorders as well as in neo-plastic diseases. The antemortem diagnosis of non-bacterial thrombotic endocarditis is rare, and most existing data result from postmortem examinations. In 3 prospective echocardiographic studies we found typical cardiac valvular lesions in patients with primary antiphospholipid syndrome, myelo-proliferative disorders, and solid malignant tumors. Cardiac lesions associated with these 3 different entities had common echocardiographic appearance and correlated positively with thromboembolic events. The possibility of common pathogenesis is suggested, and clinical significance is discussed.

[1]  Wan Ariffin Bin Abdullah,et al.  Med Pediatr Oncol , 1999 .

[2]  R Erbel,et al.  The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events. , 1999, Journal of the American College of Cardiology.

[3]  Y. Shoenfeld,et al.  Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease. , 1999, Clinical and experimental rheumatology.

[4]  B. Brenner,et al.  Cardiac valvular vegetations in cancer patients: a prospective echocardiographic study of 200 patients. , 1997, The American journal of medicine.

[5]  B. Carabello,et al.  Valvular Heart Disease , 2020, Clinical Small Animal Internal Medicine.

[6]  Y. Shoenfeld,et al.  Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves , 1996, Lupus.

[7]  G. Hughes,et al.  The management of thrombosis in the antiphospholipid-antibody syndrome. , 1995, The New England journal of medicine.

[8]  B. Sarubbi,et al.  Primary antiphospholipid syndrome and cardiovascular disease. , 1995, European heart journal.

[9]  B. Brenner,et al.  Cardiac involvement in patients with myeloproliferative disorders. , 1992, The American journal of medicine.

[10]  W. Markiewicz,et al.  Cardiac involvement in patients with primary antiphospholipid syndrome. , 1991, Journal of the American College of Cardiology.

[11]  S. Kaul,et al.  Cardiac manifestations of acquired immune deficiency syndrome: a 1991 update. , 1991, American heart journal.

[12]  P. Nihoyannopoulos,et al.  Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. , 1990, Circulation.

[13]  M. Al-Zaibag,et al.  Unusual presentation and echocardiographic features of surgically proven nonbacterial thrombotic endocarditis. , 1990, American heart journal.

[14]  B. Brenner,et al.  Abnormalities of fibrinolytic parameters in patients with myeloproliferative diseases , 1990 .

[15]  D. Tsakiris,et al.  Impaired Fibrinolysis as an Essential Contribution to Thrombosis in Patients with Lupus Anticoagulant , 1989, Thrombosis and Haemostasis.

[16]  D. Lillicrap,et al.  Thrombotic endocarditis and lupus anticoagulant. A pathogenetic possibility for idiopathic 'rheumatic type' valvular heart disease. , 1989, Archives of pathology & laboratory medicine.

[17]  A. Schorer,et al.  Lupus anticoagulant induces a selective defect in thrombin‐mediated endothelial prostacyclin release and platelet aggregation , 1989, British journal of haematology.

[18]  J. Soler‐Soler,et al.  Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. , 1988, The New England journal of medicine.

[19]  M. Fishbein,et al.  Nonbacterial thrombotic endocarditis: a review. , 1987, American heart journal.

[20]  M. Fishbein,et al.  Echocardiographic features of nonbacterial thrombotic endocarditis. , 1987, The American journal of cardiology.

[21]  C. Soria,et al.  Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant. , 1986, The New England journal of medicine.

[22]  J. Stuart,et al.  The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: An analysis of 129 cases , 1985, American journal of hematology.

[23]  S. Matsushita,et al.  Nonbacterial thrombotic endocarditis as a cause of cerebral and myocardial infarction. , 1984, Japanese circulation journal.

[24]  J. Edwards,et al.  Local complications associated with indwelling Swan-Ganz catheters: autopsy study of 36 cases. , 1983, The American journal of cardiology.

[25]  F. Rickles,et al.  Abnormalities of blood coagulation in patients with cancer: Fibrinopeptide a generation and tumor growth , 1983, Cancer.

[26]  J. Toole,et al.  Nonbacterial Thrombotic Endocarditis: A Neurologic Perspective of Clinicopathologic Correlations of 99 Patients , 1982 .

[27]  R. Siegel,et al.  Marantic endocarditis: diagnosis by 2-D echocardiography. , 1981, Chest.

[28]  G. Bodey,et al.  Nonbacterial thrombotic endocarditis in cancer patients: comparison of characteristics of patients with and without concomitant disseminated intravascular coagulation. , 1978, Medical and pediatric oncology.

[29]  J. Levin,et al.  Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. , 1977, Medicine.

[30]  B. Corya,et al.  Serial echocardiographic abnormalities in nonbacterial thrombotic endocarditis of the mitral valve. , 1976, Chest.

[31]  B. Bulkley,et al.  Mitral valve disease of systemic lupus erythematosus. A cause of severe congestive heart failure reversed by valve replacement. , 1975, The American journal of medicine.

[32]  W. Roberts,et al.  Systemic lupus erythematosus as a cause of severe mitral regurgitation. New problem in an old disease. , 1975, The American journal of cardiology.

[33]  D. Durack.  Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions , 1975, The Journal of pathology.

[34]  D. Armstrong,et al.  Nonbacterial thrombotic endocarditis in patients with malignant neoplastic diseases. , 1973, The American journal of medicine.

[35]  L. Deppisch,et al.  Non-bacterial thrombotic endocarditis: clinicopathologic correlations. , 1976, American heart journal.

[36]  A. Dawson,et al.  The influence of the platelet count on the incidence of thrombotic and haemorrhagic complications in polycythaemia vera , 1970, Postgraduate medical journal.

[37]  A. Angrist,et al.  Studies in experimental endocarditis. I. Production of valvular lesions by mechanisms not involving infection or sensitivity factors. , 1960, The American journal of pathology.

[38]  R. Macdonald,et al.  The significance of nonbacterial thrombotic endocarditis: an autopsy and clinical study of 78 cases. , 1957, Annals of internal medicine.

[39]  A. Allen,et al.  The Morphogenesis and Significance of Degenerative Verrucal Endocardiosis (Terminal Endocarditis, Endocarditis Simplex, Nonbacterial Thrombotic Endocarditis). , 1944, The American journal of pathology.

[40]  L. Gross,et al.  NONBACTERIAL THROMBOTIC ENDOCARDITIS: CLASSIFICATION AND GENERAL DESCRIPTION , 1936 .

[41]  E. Libman,et al.  A HITHERTO UNDESCRIBED FORM OF VALVULAR AND MURAL ENDOCARDITIS , 1924 .